시장보고서
상품코드
1477108

신경조절(뉴로모듈레이션) 시장 : 기술별, 용도별, 생체재료별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

Neuromodulation Market, By Technology, By Application, By Biomaterial, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 293 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

신경조절(뉴로모듈레이션) 시장 규모는 2023년 59억 8,700만 달러로 평가되었고, 2024년부터 2032년까지 연평균 11.5% 성장할 것으로 예상됩니다.

신경조절(뉴로모듈레이션) 시장 - 시장 역학

신경 질환의 유병률 증가로 시장 수요 증가

신경질환이 보편화됨에 따라 신경질환 시장이 확대되고 있습니다. 나이가 들어감에 따라 우리 몸은 감염을 퇴치하고 자가 치유하는 능력을 잃기 시작하여 당뇨병, 파킨슨병, 정형외과적 장애, 알츠하이머병, 위장병 등 많은 만성 질환에 걸리기 쉽다. 전 세계 노인 인구 증가로 인해 신경질환을 앓고 있는 사람들이 늘어나고 있습니다. 하지만 그리스, 한국, 스페인, 포르투갈, 일본, 스페인 등의 국가에서는 노인 인구의 비율이 훨씬 높아 2050년까지 이들 국가의 인구 중 40%가 65세 이상이 될 것으로 예상되며, 2050년까지 65세 이상 인구는 전 세계적으로 거의 세 배로 증가할 것으로 예상됩니다. 증가될 것으로 예상됩니다. 따라서 신경 조절 장치의 보급은 신경 질환의 높은 유병률을 특징으로 하는 고령화 인구의 현저한 증가에 의해 촉진될 것으로 예상됩니다. 이는 예측 기간 동안 전 세계 신경절제술 시장의 확대에 기여할 것으로 보입니다.

신경조절(뉴로모듈레이션) 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 11.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

기술별로는 체내 신경조절이 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.

용도별로는 파킨슨병 분야가 예측 기간 동안 시장을 주도할 것으로 예상됩니다.

지역별로는 북미가 2023년 매출을 주도했습니다.

신경조절(뉴로모듈레이션) 시장 - 세분화 분석 :

세계 신경조절(뉴로모듈레이션) 시장은 기술, 용도, 생체재료, 지역별로 세분화되어 있습니다.

기술에 따라 시장은 내부 신경절제술과 외부 신경절제술로 분류됩니다. 예측 기간 동안 내부 신경절제술 분야가 가장 높은 CAGR로 성장할 것으로 예상됩니다. 만성 신경 질환 및 통증 질환을 앓고 있는 환자들은 표적화되고 조절 가능한 자극을 제공하는 내부 신경 변조 요법을 사용하여 증상을 크게 완화할 수 있습니다. 이러한 치료법의 효과와 적용은 기술 발전과 함께 더욱 개선될 것으로 예상되며, 이는 내부 신경조절 분야 시장 확대를 촉진할 것으로 보입니다.

용도별로는 편두통, 만성통증, 요통, 요실금, 요실금/변실금, 파킨슨병, 간질, 진전, 우울증, 기타로 분류됩니다. 파킨슨병 분야는 고령화 인구 증가로 인해 예측 기간 동안 시장을 주도할 것으로 예상됩니다.

신경조절(뉴로모듈레이션) 시장 - 지리적 통찰력

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 나뉩니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 예측 기간 동안 북미가 시장을 지배할 것으로 예상됩니다. 대규모 제약 및 바이오 제약 산업과 잘 알려진 시장 기업의 존재, 첨단 기술 도입을 위한 미국 내 투자 확대가 시장 확대를 견인할 것으로 예상됩니다. 예를 들어, 파킨슨 재단이 발표한 최신 데이터에 따르면 2022년 미국 내 파킨슨병(PD) 연간 진단 건수는 약 9만 건에 달할 것으로 예상되며, 이는 기존 예측치인 6만 건보다 50% 증가한 수치입니다.

신경조절(뉴로모듈레이션) 시장 - 경쟁 구도:

시장에 진출한 주요 기업으로는 Bioventus Inc, Medtronic, Nevro Corporation, Neuronetics, MicroTransponder, NeuroPace Inc, MicroTransponder, LivaNova PLC, Abbott, NeuroSigma 등이 있습니다. 이들 기업은 제품 출시, 인수, 사업 확장 등 시장 점유율을 극대화하기 위해 여러 가지 전략을 채택하고 있습니다.

목차

제1장 신경조절(뉴로모듈레이션) 시장 개요

  • 조사 범위
  • 시장 추정 년도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 신경조절(뉴로모듈레이션) 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 신경조절(뉴로모듈레이션) 산업 연구

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 신경조절(뉴로모듈레이션) 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 신경조절(뉴로모듈레이션) 시장 구도

  • 신경조절(뉴로모듈레이션) 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 신경조절(뉴로모듈레이션) 시장 - 기술별

  • 개요
    • 기술별 부문 점유율 분석
    • 내부 신경조절
    • 외부 신경조절

제8장 신경조절(뉴로모듈레이션) 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 편두통
    • 만성 통증
    • 척추 수술 실패 증후군
    • 요실금 및 변실금
    • 파킨슨병
    • 간질
    • 진전
    • 우울증
    • 기타

제9장 신경조절(뉴로모듈레이션) 시장 - 바이오소재별

  • 개요
    • 바이오소재별 부문 점유율 분석
    • 고분자 생체 재료
    • 금속 바이오소재
    • 세라믹 바이오소재

제10장 신경조절(뉴로모듈레이션) 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 신경조절(뉴로모듈레이션) 업계

  • 경쟁 대시보드
  • 기업 개요
    • Bioventus Inc.
    • Medtronic
    • Nevro Corporation
    • Neuronetics
    • MicroTransponder
    • NeuroPace Inc
    • Boston Scientific Corporation
    • MicroTransponder
    • LivaNova PLC
    • Abbott
    • NeuroSigma

제12장 애널리스트의 전방위 전망

LSH 24.05.28

REPORT HIGHLIGHT

Neuromodulation Market size was valued at USD 5,987 Million in 2023, expanding at a CAGR of 11.5% from 2024 to 2032.

One technological advancement that directly affects nerves is neuromodulation. It is the change in nerve activity brought on by the direct application of medication or electricity to a specific location. The neuromodulation market uses state-of-the-art tools and therapies. They have an impact on every bodily system and are effective in treating almost all conditions, such as incontinence, tremors, migraines, and spinal cord injuries.

Neuromodulation Market- Market Dynamics

Increasing prevalence of neurological disorder to propel market demand

The neuromodulation market is expanding as neurological problems become more common. As we age, our bodies begin to lose their capacity to fight off infections and repair themselves, which leaves us more vulnerable to a host of chronic conditions like diabetes, Parkinson's disease, orthopedic difficulties, Alzheimer's disease, and gastrointestinal problems. There is an increasing number of people with neurological illnesses due to the global increase in the older population. Nonetheless, the percentage of the elderly population is much higher in nations like Greece, South Korea, Spain, Portugal, Japan, and Spain; by 2050, 40% of these nations' populations are predicted to be over 65. The number of people 65 years of age or older is expected to nearly treble globally by 2050. Therefore, the adoption of neuromodulation devices is projected to be driven by the notable increase in the ageing population, which is marked by a high prevalence of neurological illnesses. This will contribute to the expansion of the worldwide neuromodulation market throughout the forecast period.

Neuromodulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2024-2032)

Based on technology, the Internal Neuromodulation segment is expected to grow at the highest CAGR during the forecast period

Based on application segmentation, the Parkinson's Disease segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Neuromodulation Market- Segmentation Analysis:

The Global Neuromodulation Market is segmented based on Technology, Application, Biomaterial, and Region.

Based on the technology, the market is categorized into Internal Neuromodulation and External Neuromodulation. The Internal Neuromodulation segment is expected to grow at the highest CAGR during the forecast period. Patients with chronic neurological and pain diseases may find significant alleviation from their symptoms with the use of internal neuromodulation therapies, which give targeted and adjustable stimulation. The efficacy and application of these therapies are anticipated to improve with additional technological advancements, fueling further market expansion in the internal neuromodulation segment.

Based on the application, the industry is divided into Migraine, Chronic Pain, Failed Back Syndrome, Urinary And Fecal Incontinence, Parkinson's Disease, Epilepsy, Tremor, Depression and Others. The Parkinson's Disease segment is expected to lead the market over the projected period owing to the growing ageing population.

Neuromodulation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The large pharmaceutical and biopharmaceutical industries, together with the presence of well-established market players and growing investments in the United States for the adoption of cutting-edge technologies, are anticipated to drive the market's expansion in the nation. According to updated data from the Parkinson's Foundation in 2022, for example, the yearly diagnosis rate of Parkinson's disease (PD) in the United States is anticipated to be about 90,000, a 50% rise from the previous projection of 60,000 diagnoses.

Neuromodulation Market- Competitive Landscape:

The key players operating in the market include Bioventus Inc., Medtronic, Nevro Corporation, Neuronetics, MicroTransponder, NeuroPace Inc., Boston Scientific Corporation, MicroTransponder, LivaNova PLC, Abbott and NeuroSigma. These players adopted several strategies to capture the maximum market share such as product launch, acquisition, expansion and others.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bioventus Inc.

Medtronic

Nevro Corporation

Neuronetics

MicroTransponder

NeuroPace Inc

Boston Scientific Corporation

MicroTransponder

LivaNova PLC

Abbott

NeuroSigma

GLOBAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Internal Neuromodulation
  • External Neuromodulation

GLOBAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Migraine
  • Chronic Pain
  • Failed Back Syndrome
  • Urinary And Fecal Incontinence
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Others

GLOBAL NEUROMODULATION MARKET, BY BIOMATERIAL- MARKET ANALYSIS, 2019 - 2032

  • Polymeric Biomaterials
  • Metallic Biomaterials
  • Ceramic Biomaterials

GLOBAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Neuromodulation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Neuromodulation Market Snippet by Technology
    • 2.1.2.Neuromodulation Market Snippet by Application
    • 2.1.3.Neuromodulation Market Snippet by Biomaterial
    • 2.1.4.Neuromodulation Market Snippet by Country
    • 2.1.5.Neuromodulation Market Snippet by Region
  • 2.2.Competitive Insights

3.Neuromodulation Key Market Trends

  • 3.1.Neuromodulation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Neuromodulation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Neuromodulation Market Opportunities
  • 3.4.Neuromodulation Market Future Trends

4.Neuromodulation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Neuromodulation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Neuromodulation Market Landscape

  • 6.1.Neuromodulation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Neuromodulation Market - By Technology

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2.Internal Neuromodulation
    • 7.1.3.External Neuromodulation

8.Neuromodulation Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Migraine
    • 8.1.3.Chronic Pain
    • 8.1.4.Failed Back Syndrome
    • 8.1.5.Urinary And Fecal Incontinence
    • 8.1.6.Parkinson Disease
    • 8.1.7.Epilepsy
    • 8.1.8.Tremor
    • 8.1.9.Depression
    • 8.1.10.Others

9.Neuromodulation Market - By Biomaterial

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Biomaterial, 2023 & 2032 (%)
    • 9.1.2.Polymeric Biomaterials
    • 9.1.3.Metallic Biomaterials
    • 9.1.4.Ceramic Biomaterials

10.Neuromodulation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Neuromodulation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Neuromodulation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Neuromodulation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Neuromodulation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Neuromodulation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Biomaterial, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Neuromodulation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Bioventus Inc.
    • 11.2.2.Medtronic
    • 11.2.3.Nevro Corporation
    • 11.2.4.Neuronetics
    • 11.2.5.MicroTransponder
    • 11.2.6.NeuroPace Inc
    • 11.2.7.Boston Scientific Corporation
    • 11.2.8.MicroTransponder
    • 11.2.9.LivaNova PLC
    • 11.2.10.Abbott
    • 11.2.11.NeuroSigma

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Biomaterialology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제